A carregar...
Chimeric antigen receptor–engineered T cells as oncolytic virus carriers
The use of engineered T cells in adoptive transfer therapies has shown significant promise in treating hematological cancers. However, successes treating solid tumors are much less prevalent. Oncolytic viruses (OVs) have the capacity to induce specific lysis of tumor cells and indirectly impact tumo...
Na minha lista:
| Publicado no: | Mol Ther Oncolytics |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782951/ https://ncbi.nlm.nih.gov/pubmed/27119109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2015.14 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|